ICT-02

N/A

Report date: 2025/01/26 17:39:34

Base Information

Drug NameICT-02
Drug Alias NameBTLA checkpoint inhibitor (ImmCheck Therapeutics)ICT-02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionB- and T-lymphocyte attenuator blockers
TargetsB- and T-lymphocyte attenuator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImCheck Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesImCheck Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A